Dipyridamole contraindications

Revision as of 02:27, 7 February 2014 by ShiSheng (talk | contribs) (Created page with " __NOTOC__ {{Dipyridamole}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== Hypersensitivity to dipyridamole and any of the other components.<ref name="dailymed.nlm.nih.gov...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Dipyridamole
PERSANTINE® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

Hypersensitivity to dipyridamole and any of the other components.[1]

References

  1. "PERSANTINE (DIPYRIDAMOLE) TABLET, COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]". Retrieved 7 February 2014.

Template:WikiDoc Sources